Dr. Muyembe set out on his path to an Ebola treatment during the 1995 outbreak. He transferred blood from five survivors to eight patients, hoping that the antibodies that kept some people alive would keep others from dying. Seven of the patients who received the blood transfusion recovered.
There is also another 2-dose vaccine that is actually being distributed. I don't know much about it, but requiring a second dose likely means it's a protein fragment or attenuated Ebola virus, likely making it more heat stable and actually easier to distribute. Compliance is an issue, but it has proven effective in ring vaccination usage (vaccination of those around people who have contracted the disease).
There's also been some initiative to grow human Ebola antibodies in crops and distribute those as well.
As usual, the primary challenge to stopping Ebola spread is the political and social climate in the war torn DRC.
https://www.cbc.ca/news/canada/manitoba/ebola-henipah-china-...
> In August 2019, the Democratic Republic of the Congo’s national health authorities, the World Health Organization, and the National Institutes of Health announced that they would stop using ZMapp, along with all other Ebola treatments except REGN-EB3 and mAb114, in their ongoing clinical trials, citing the higher mortality rates of patients not treated with REGN-EB3 and mAb114
From https://en.wikipedia.org/wiki/ZMapp#Use_during_the_2014%E2%8...
So seems it's just used in some cases today.
The paywall issue has been discussed extensively. If there's a workaround, it's ok. Users usually post workarounds in the threads.
This is in the FAQ at https://news.ycombinator.com/newsfaq.html and there's more explanation here:
https://news.ycombinator.com/item?id=10178989
https://hn.algolia.com/?sort=byDate&dateRange=all&type=comme...
